Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a high heterogeneous group of tumors with a distinctly aggressive nature and high rates of relapse. So far, the lack of any known targetable proteins has not allowed a specific anti-tumor treatment. Therefore, the identification of novel agents for specific TN...

Descripción completa

Detalles Bibliográficos
Autores principales: Camorani, Simona, Granata, Ilaria, Collina, Francesca, Leonetti, Francesco, Cantile, Monica, Botti, Gerardo, Fedele, Monica, Guarracino, Mario Rosario, Cerchia, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103779/
https://www.ncbi.nlm.nih.gov/pubmed/32222697
http://dx.doi.org/10.1016/j.isci.2020.100979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103779/
https://www.ncbi.nlm.nih.gov/pubmed/32222697
http://dx.doi.org/10.1016/j.isci.2020.100979

Ejemplares similares